Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 51 - 100 out of 30,558

Document Document Title
WO/2016/175533A3
The purpose of the present invention is to provide: a compound having a high light emitting efficiency, a low driving voltage, and an improved lifespan of an element; an organic electronic element using the same; and an electronic device...  
WO/2016/173274A1
Aromatic farnesyl compound and application of a pharmaceutical salt thereof as an inhibitor of α-glucosidase, dipeptidyl peptidase-4, aldose reductase, protein tyrosine phosphatase-1B or HMG-CoA reductase, or use thereof in preparing me...  
WO/2016/168938A1
Described herein is an antibiotic compound of formula (I): or a salt or stereoisomer thereof; wherein R1-R3, R5 and R6 are independently selected from H, alkyl group, substituted alkyl group, halogen, OH, NH2, or SH; R4 is H, alkyl group...  
WO/2016/172655A1
Disclosed herein are compounds, salts, solvates of Formula (1), and any formulation thereof. Also disclosed are methods of eliciting hydraulic enhancement and/or increasing yield of a plant by contacting a plant with compounds, salts, so...  
WO/2016/172556A1
In one aspect, methods of HMF production are described herein. A method of HMF production, in some embodiments, comprises providing a saccharide feedstock including glucose and bringing the saccharide feedstock into contact with a solid ...  
WO/2016/171429A3
The present invention relates to any one anthracene derivative selected from [Chemical Formula A-1], [Chemical Formula A-2], [Chemical Formula B-1] and [Chemical Formula B-2], and to an organic light emitting diode including the anthrace...  
WO/2016/169573A1
The present invention relates to potent HCV entry inhibitors (cynaropicrin and grosheimol), in addition to mono-caffoeylquinic acid derivatives which have also anti-HCV activity but less than cynaropicrin and grosheimol.  
WO/2016/171429A2
The present invention relates to any one anthracene derivative selected from [Chemical Formula A-1], [Chemical Formula A-2], [Chemical Formula B-1] and [Chemical Formula B-2], and to an organic light emitting diode including the anthrace...  
WO/2016/168058A1
This disclosure relates to the field of molecules having pesticidal utility against pests in Phyla Arthropoda, Mollusca, and Nematoda, processes to produce such molecules, intermediates used in such processes, pesticidal compositions con...  
WO/2016/166421A1
According to an example aspect of the present invention, there is provided a method of producing furan carboxylates from aldaric acids in the presence of a solid heterogeneous catalyst and a solvent with short reaction time. The feedstoc...  
WO/2016/167491A1
The present invention provides a compound represented by chemical formula 1. In addition, the present invention provides an organic electronic element comprising a first electrode, a second electrode, and an organic material layer betwee...  
WO/2016/168675A1
Provided is a method of producing activated carbon from a resin composite made up of furanic polymer. The method includes producing a resin composite from feedstock (e.g., in the presence of an acid and a salt), combining the resin compo...  
WO/2016/168233A1
An integrated process is described for producing 2,5-furandicarboxylic acid and/or a derivative thereof from a six carbon sugar-containing feed, comprising: a) dehydrating a feed comprising a six-carbon sugar unit, in the presence of a b...  
WO/2016/164828A1
PLGA-based polymers include pendant nucleophiles protected with photocleavable protecting groups. Upon deprotection, the polymers degrade rapidly via intramolecular cyclization into small molecules. The polymer may be formulated as a nan...  
WO/2016/163276A1
[Problem] To provide an organic electroluminescent element which has low driving voltage, high luminous efficiency and a long service life by combining various materials for organic electroluminescent elements having excellent injection/...  
WO/2016/162397A1
The present invention provides a process for the production of THF and 1,4-BDO from furan in the presence of a catalytic composition, wherein the catalytic composition contains at least one metal selected from the group consisting of Fe,...  
WO/2016/162646A1
The present invention relates to a method for preparing a precursor of a single dairy-lactone isomer, to a single dairy-lactone isomer, and to the organoleptic uses thereof.  
WO/2016/161279A1
There are disclosed compounds of formula (I) that modulate or inhibit the enzymatic activity of indoleamine-2,3-dioxygenase (IDO), pharmaceutical compositions containing said compounds and methods of treating proliferative disorders, suc...  
WO/2016/158788A1
The present invention relates to: a fused heterocyclic compound that has enteropeptidase inhibitory activity; and use of the compound as a pharmaceutical product for treatment or prophylaxis of obesity, diabetes and the like. Specificall...  
WO/2016/159021A1
[Problem] To provide a novel compound. [Solution] A compound represented by formula (I) or formula (II), a salt thereof, or a solvate thereof. R1 represents a hydrogen atom or a halogen atom; each of R2-R4 represents a hydrogen atom, a h...  
WO/2016/158706A1
The purpose of the present invention is to provide an industrially advantageous method for producing a furan compound, by which a furan compound is able to be efficiently obtained from a furfural compound with high selectivity. The prese...  
WO/2016/157052A1
The present invention provides compounds represented by formula (1A), or pharmaceutically acceptable salts. Compounds represented by formula (1A), or pharmaceutically acceptable salts thereof, wherein A1 and A2 are identical or different...  
WO/2016/153937A1
A method for synthesizing furan-2, 5-dicarboxylate (FDCA2-) is provided. Furan-2-carboxylic acid is provided. A CO3 2- salt is provided to form a mixture, which converts the furan-2-carboxylic acid to furan-2-carboxylate. CO2 gas is prov...  
WO/2016/151989A1
The present invention can provide novel C-glycoside derivatives which are biologically important under high stereoselective, mild, atom economical condition.  
WO/2016/154599A1
Catalysts useful for the selective hydrogenation of carbonyl groups, including for the reduction of aldehydes to alcohols, are described. The catalysts incorporate palladium and rhenium on an alumina support. Methods of making the cataly...  
WO/2016/153432A1
The present invention relates to substituted phenyl cinnamyl ketones of Formula (I) for use in therapy: wherein R1 to R11 are defined as described in the specification, or a pharmaceutically acceptable salt, tautomer(s), solvate or polym...  
WO/2016/154241A1
The present invention provides, among other things, compounds represented by the general Formula I: (I) and pharmaceutically acceptable salts thereof, wherein L and A (and further substituents) are as defined in classes and subclasses he...  
WO/2016/146769A1
A method of selective conversion of Abienol, represented by formula 1, to Sclareodial, represented by formula 2 by ozonolysis and subsequent reduction. The ozonolysis is carried out at temperatures above -60 °C, preferably in nonhalogen...  
WO/2016/148425A2
The present invention provides a compound represented by Chemical Formula 1. In addition, the present invention provides an organic electric device including a first electrode, a second electrode, and an organic layer between the first e...  
WO/2016/146752A1
The present invention pertains to a method for manufacturing furan-2, 5-dicarboxylic acid (FDCA) by converting a furan-2,5- dicarboxylate salt (MFDC) into furan-2, 5-dicarboxylic acid (FDCA), comprising the steps of - combining solid MFD...  
WO/2016/145478A1
The present invention relates to novel compounds and their use in the prophylactic and/or therapeutic treatment of kidney and/or liver disease.  
WO/2016/148425A3
The present invention provides a compound represented by Chemical Formula 1. In addition, the present invention provides an organic electric device including a first electrode, a second electrode, and an organic layer between the first e...  
WO/2016/146689A1
Provided is an organozinc composition comprising (a) an organozinc complex carrying an allylic ligand, (b) a magnesium component and (c) a lithium component. The organozinc composition is useful as a synthetic intermediate with excellent...  
WO/2016/149461A1
The present disclosure provides methods to produce 5-(halomethyl)furfural, including 5- (chloromethyl)furfural, by acid-catalyzed conversion of C6 saccharides, including isomers thereof, polymers thereof, and certain derivatives thereof.  
WO/2016/145532A1
Described are methods and uses for treating or preventing fatty liver disease. Also provided are methods and uses for the treatment or prevention of insulin resistance. Carboxy-4-methyl-5-propyl-2-furanpropanoic acid (CMPF) is shown to p...  
WO/2016/146753A1
The invention pertains to a method for manufacturing furan-2,5-dicarboxylic acid (FDCA) by converting a furan-2,5-dicarboxylate salt (MFDC) into furan-2,5-dicarboxylic acid (FDCA), comprising the steps of combining an aqueous solution of...  
WO/2016/141148A1
The present invention provides a method of preparing a furan derivative comprising the steps of (a) converting a monosaccharide to provide a keto-intermediate product; and (b) dehydrating the keto-intermediate product to provide a furan ...  
WO/2016/137832A1
The disclosure provides compounds of formula I, including their salts, as well as compositions and methods of using the compounds. The compounds have activity against hepatitis C virus (HCV) and may be useful in treating those infected w...  
WO/2016/135268A1
The invention relates to a method for preparing a chemical compound from a starting compound in a contaminant containing feedstock, wherein the feedstock comprises a contaminant, wherein the contaminant is selected from the group consist...  
WO/2016/135009A1
The invention relates to process for the preparation of gamma valerolactone (GVL) from levulinic acid (LA), said process comprising a) subjecting LA to a hydrogenation reaction comprising hydrogen and a solid catalyst system comprising a...  
WO/2016/135542A1
A process for the production of dipentyl ether from levulinic acid resulting from biomass including at least one polysaccharide comprising the following steps: (a) reacting said levulinic acid in the presence of hydrogen and at least one...  
WO/2016/137068A1
The present specification provides a hetero ring compound and an organic luminescent element comprising same.  
WO/2016/135070A1
The invention provides novel compounds having the general formula (I) wherein R1, R2, R3, R4, R5, R6 and R7 are as described herein, compositions including the compounds and methods of using the compounds.  
WO/2016/133972A1
Compounds of Formula I, including their salts, as well as compositions and methods of using the compounds are set forth. The compounds have activity against hepatitis C virus (HCV) and are useful in treating those infected with HCV:  
WO/2016/131098A1
ABSTRACT The present invention provides for certain sulfonyl ureas and related compounds which have advantageous properties and show useful activity in the inhibition of activation of the NLRP3 inflammasome. Such compounds are useful in ...  
WO/2016/133970A1
Compounds of Formula (I), including their salts, as well as compositions and methods of using the compounds are set forth. The compounds have activity against hepatitis C virus (HCV) and are useful in treating those infected with HCV.  
WO/2016/133963A1
Compounds of Formula I, including their salts, as well as compositions and methods of using the compounds are set forth. The compounds have activity against hepatitis C virus (HCV) and areuseful in treating those infected with HCV.  
WO/2016/133160A1
The purpose of the present invention is to provide a novel low molecular weight compound that exhibits orexin receptor agonist activity and is expected to be useful as an excellent preventative or therapeutic agent for narcolepsy or the ...  
WO/2016/134013A1
A diesel fuel and additive mixture is useful for reducing particulate matter emissions while improving or at least not aggravating oxidative stability during combustion. The additive includes at least one compound having a general formul...  
WO/2016/131821A1
The invention relates to a continuous or repetitive batch process for the hydrogenation of levulinic acid (LA) or esters thereof to at least gamma valerolactone (GVL) in a reactor comprising a feed stream and an outlet stream, in the pre...  

Matches 51 - 100 out of 30,558